NET PROFIT (x1000 NOK)
EMPLOYEES
Active Biotech AB (publ)
Closing information (x1000 NOK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
216
|
241
|
506 |
| Earnings before taxes |
-40,631
|
-46,397
|
-55,215 |
| EBITDA |
-41,088
|
-47,090
|
-54,755 |
| Total assets |
44,536
|
44,621
|
48,246 |
| Current assets |
40,437
|
39,214
|
41,734 |
| Current liabilities |
9,187
|
10,515
|
11,410 |
| Equity capital |
33,768
|
31,067
|
32,644 |
| - share capital |
6,552
|
1,892
|
1,294 |
| Employees (average) |
7
|
8
|
9 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
75.8%
|
69.6%
|
67.7% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-90.7%
|
-103.4%
|
-113.4% |
| Current ratio |
440.2%
|
372.9%
|
365.8% |
| Return on equity (ROE) |
-120.3%
|
-149.3%
|
-169.1% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
-1
|
-1
|
1 |
| Chg. No. of employees % |
-13%
|
-11%
|
13% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.